在心血管疾病中使用秘体和外体
Eka Ginanjar1, Zahra Nuril Anwar2
1Cardiovascular Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia - Cipto Mangunkusumo Hospital, Jakarta, Indonesia. ekaginanjar.md@gmail.com.
Acta medica Indonesiana
|October 6, 2025
概括
秘密体和外体在治疗心血管疾病 (CVD) 方面表现有前途,通过帮助组织修复和减少炎症. 进一步的研究将释放它们在先进心血管疾病治疗中的全部潜力.
科学领域:
- 再生医学是一种再生医学.
- 心血管生物学 心血管生物学
- 细胞生物学 细胞生物学
背景情况:
- 心血管疾病 (CVD) 是一个主要的全球健康问题.
- 机密体和外体是细胞间通信的关键媒介.
- 再生医学的进步突出了它们对心血管疾病的治疗潜力.
研究的目的:
- 阐明在心血管生理学和病理学中分泌体和外泌体的作用.
- 探索秘密体和外体在缓解心血管疾病进展方面的治疗应用.
主要方法:
- 关于心血管系统中的分泌体和外泌体功能的当前文献的综述.
- 分析它们在细胞间通信,组织修复和免疫调节中的机制.
主要成果:
- 机密体和外体在减少心血管疾病进展方面表现出显著的潜力.
- 关键的机制包括抑制炎症和促进血管生成.
- 它们还在调节与心血管健康相关的重要生物通路方面发挥作用.
结论:
- 秘密体和外体是对心血管疾病有前途的治疗药物.
- 它们在细胞间通信,修复和免疫调节中的作用至关重要.
- 需要进一步研究以优化它们在先进心血管治疗中的临床应用.
相关概念视频
Overview of Exosomes
3.5K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.5K
Regulation of the Cardiovascular System
3.7K
The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.7K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
538
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
538
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
794
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
794


